Improved Formulations and Delivery Methods Other advancements include longer-acting formulations that may eventually require less frequent dosing, improved delivery methods that enhance comfort and convenience, and combination approaches that pair GLP-1 therapy with complementary treatments
The FDA says Wegovy is approved to "reduce excess weight and maintain weight reduction long term in certain adults with obesity or overweight and certain children with obesity, for use in addition to a reduced calorie diet and increased physical activity." COST: The cost of Wegovy in India ranges from 17,345 to 26,015 per month, depending on the dosage
Maximum amount financed $150,000, inclusive of tax, title, & license which are due at signing
E.JavorskM.et al (2017)
What is your revenue model and pricing strategy
There are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see Clinical Considerations)